Blood Safety, Laboratories and Health Technology

Print

The Blood Safety, Laboratories & Health Technology Programme Area Component supports Member states in attaining improved health and reduced morbidity and mortality through the safety, availability and appropriate use of essential health technologies within health systems.


Experts agree to develop robust blood transfusion services in Ebola affected and unaffected countries

Experts agree to develop robust blood transfusion services in Ebola affected and unaffected countries

Brazzaville, 8 June 2015 - Blood safety experts have agreed to develop robust blood transfusion services (BTS) in Ebola affected and unaffected countries to enhance preparedness for future outbreaks of infections with epidemic potential. Strengthening BTS would also have a direct benefit for tackling regional public health priorities including maternal and child mortality.